0580041 - ÚOCHB 2024 RIV eng P - Patent Document
Slusher, B. - Rais, R. - Riggins, G. - Majer, Pavel - Tichý, Tomáš - Vávra, Jan - Jančařík, Andrej - Tenora, Lukáš
Mebendazole prodrugs with enhanced solubility and oral bioavailability.
2023. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 14.09.2023. Patent Number: AU2019216757. Territorial Protection: národní patent v zemi mimo EU ,mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci.
Institutional support: RVO:61388963
Keywords : mebendazole * prodrug * oral bioavailability
OECD category: Medicinal chemistry
https://worldwide.espacenet.com/patent/search/family/067549070/publication/AU2019216757B2?q=AU2019216757B2
Permanent Link: https://hdl.handle.net/11104/0348822
Slusher, B. - Rais, R. - Riggins, G. - Majer, Pavel - Tichý, Tomáš - Vávra, Jan - Jančařík, Andrej - Tenora, Lukáš
Mebendazole prodrugs with enhanced solubility and oral bioavailability.
2023. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 14.09.2023. Patent Number: AU2019216757. Territorial Protection: národní patent v zemi mimo EU ,mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci.
Institutional support: RVO:61388963
Keywords : mebendazole * prodrug * oral bioavailability
OECD category: Medicinal chemistry
https://worldwide.espacenet.com/patent/search/family/067549070/publication/AU2019216757B2?q=AU2019216757B2
Permanent Link: https://hdl.handle.net/11104/0348822